Trial of Exenatide for Parkinson's Disease

NCT01971242 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Exenatide
OTHER: Placebo

Sponsor

University College, London